- Published at
- by marketscreener.com
positive
positive
MYND Lifesciencs : Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal for $3 Million Clinical Trial
Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression
VANCOUVER, BC, Oct. 13, 2021 /PRNewswire/ - MYND Diagnostics Inc., a wholly-owned... | October 13, 2021